Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schlomm

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Prostate|October 26, 2011
Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the geneA Fleischmann, H Huland, M Mirlacher, et al.
Der Urologe. Ausg. A|April 5, 2014
[Prognostic and predictive molecular markers for urologic cancers]A Hartmann, T Schlomm, S Bertz, et al.
Prostate Cancer and Prostatic Diseases|November 25, 2010
Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinomaO J C Hellwinkel, L E Asong, J-P Rogmann, et al.
Der Urologe. Ausg. A|February 15, 2008
[Active surveillance for prostate cancer]M Graefen, S Ahyai, R Heuer, et al.
Oncology Letters|September 12, 2012
Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patientsJ Köllermann, H Albrecht, T Schlomm, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 12, 2014
Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: does the anaesthetic technique matter?M Roiss, J Schiffmann, P Tennstedt, et al.
World Journal of Urology|July 4, 2014
No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancerK Boehm, B Beyer, P Tennstedt, et al.
Prostate Cancer and Prostatic Diseases|January 23, 2013
High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomyM C Tsourlakis, E Walter, A Quaas, et al.
Oncogene|September 23, 2014
UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylationH M Itkonen, N Engedal, E Babaie, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 21, 2012
Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomyJ Schmitges, Q-D Trinh, L Jonas, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Prostate|October 26, 2011
Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the geneA Fleischmann, H Huland, M Mirlacher, et al.
Der Urologe. Ausg. A|April 5, 2014
[Prognostic and predictive molecular markers for urologic cancers]A Hartmann, T Schlomm, S Bertz, et al.
Prostate Cancer and Prostatic Diseases|November 25, 2010
Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinomaO J C Hellwinkel, L E Asong, J-P Rogmann, et al.
Der Urologe. Ausg. A|February 15, 2008
[Active surveillance for prostate cancer]M Graefen, S Ahyai, R Heuer, et al.
Oncology Letters|September 12, 2012
Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patientsJ Köllermann, H Albrecht, T Schlomm, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 12, 2014
Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: does the anaesthetic technique matter?M Roiss, J Schiffmann, P Tennstedt, et al.
World Journal of Urology|July 4, 2014
No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancerK Boehm, B Beyer, P Tennstedt, et al.
Prostate Cancer and Prostatic Diseases|January 23, 2013
High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomyM C Tsourlakis, E Walter, A Quaas, et al.
Oncogene|September 23, 2014
UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylationH M Itkonen, N Engedal, E Babaie, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 21, 2012
Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomyJ Schmitges, Q-D Trinh, L Jonas, et al.
Pageof 3